COMMUNIQUÉS West-GlobeNewswire

Rapport Therapeutics to Participate in Upcoming Investor Conferences

22/04/2025 - 13:00

BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

22/04/2025 - 13:00

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses pacemaker-indicated [...]

Axsome Therapeutics to Participate in Upcoming Investor Conferences

22/04/2025 - 13:00

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it [...]

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

22/04/2025 - 13:00

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report first quarter 2025 financial results on Tuesday, May 6, 2025, after market close. [...]

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

22/04/2025 - 13:00

ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial [...]

Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader

22/04/2025 - 13:00

Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June 2025 Two parallel [...]

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

22/04/2025 - 13:00

CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company [...]

Transactions in Connection with Share Buy-back Program

22/04/2025 - 13:23

Company Announcement COPENHAGEN, Denmark; April 22, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce [...]

Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

22/04/2025 - 13:30

Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has the potential to be the first approved therapy and standard of care for microcystic lymphatic [...]

BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET

22/04/2025 - 13:30

PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it [...]

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

22/04/2025 - 13:30

Over 75 patients enrolled in BriaCell’s pivotal Phase 3 study of Bria-IMT ™ plus immune check point inhibitor in metastatic breast cancer (MBC) 54 clinical sites across 15 states currently enrolling patients including [...]

Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference

22/04/2025 - 13:30

ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in [...]

Best Female Libido Boosters 2025 and Sexual Enhancement Pills for Women - By Oh Yes

22/04/2025 - 13:34

Rhyl, Wales, April 22, 2025 (GLOBE NEWSWIRE) -- A healthy sex life plays an important role in a woman's relationships, mental health, and confidence. However, nearly 1 in 3 women have sexual problems that can erode [...]

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences

22/04/2025 - 14:00

CARMEL, Ind., April 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]

InnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025

22/04/2025 - 14:00

DENVER, April 22, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible [...]

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

22/04/2025 - 14:00

GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first [...]

March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma

22/04/2025 - 14:00

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseases HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an emerging [...]

Invitation to Orion’s Capital Markets Day on 22 May 2025

22/04/2025 - 08:00

ORION CORPORATION INVESTOR NEWS 22 APRIL 2025 at 9.00 EEST Invitation to Orion’s Capital Markets Day on 22 May 2025 Orion invites analysts, institutional investors, bankers and media representatives to its Capital [...]

Mitolyn Reviews (Investigative Warning 2025): A Comprehensive Review of the Revolutionary Mitochondrial and Cellular Health Supplement

22/04/2025 - 08:23

The Mitolyn Effect—Real-Life Transformations Backed by Cutting-Edge Science New York City, April 22, 2025 (GLOBE NEWSWIRE) -- The recent energy drops together with slowing metabolic processes and cognitive decline [...]